Anti-lymphangiogenic action of SAHA on breast cancer
博士 === 國立中山大學 === 生物醫學研究所 === 101 === HDAC inhibitor suberoylanilide hydroxamic acid (SAHA) exhibits anti-tumor effects on various types of human cancers and is now approved by U.S FDA for clinical cancer treatment. SAHA also suppresses tumor angiogenesis. However, the effect of SAHA on tumor lympha...
| Main Authors: | , |
|---|---|
| Other Authors: | |
| Format: | Others |
| Language: | en_US |
| Published: |
2013
|
| Online Access: | http://ndltd.ncl.edu.tw/handle/37812556370839855915 |